EGFR and diabetes mellitus: Further, consistent with ARBs known inhibition of Angiotensin II-mediated transactivation of EGFR, diabetic hearts treated with Losartan reduced EGFR phosphorylation compared to untreated diabetes following I/R (Figure 10).